Trypsinization is the term for the process of cell separation. A proteolytic enzyme converts proteins to detach adherent cells from the container in that they are cultivated using the cell separation process. The proteolytic enzyme is used to divide the proteins to detach adherent cells from the vessel as they are refined. Furthermore, the cell dissociation chemicals have stiffness of the material and proteolytic activity to detach tissues and v cell lines from glass or plastic surfaces, resulting in higher isolation efficiency and cell survival.
The global Cell Dissociation market was valued at USD 285.2 million in 2020, growing with a CAGR of 13.1% during the forecast period, 2021-2027. The biopharmaceutical business is a fast-growing area of the pharmaceutical sector, with huge ramifications for healthcare. As a result of the high efficacy and safety of these treatments, opportunities in biopharma have grown during the last decade. Biopharmaceuticals have a number of advantages, including very effective and powerful action, lesser side effects, and the possibility to cure diseases rather than just treat symptoms, all of which have boosted demand for biopharmaceuticals.
North America held the highest proportion of the cell dissociation market in 2020. North America’s substantial share is mostly due to increased research in the biotechnology industries, as well as the strong presence of leading market participants in this area. Furthermore, projections for stem cell-based research accessible on the National Institute of Health portal show a total funding allocation of more than USD 3 billion for study in diverse domains of stem cell applications. Furthermore, the presence of a large number of chemical and lab testing providers in the United States, who are capable of offering both enzymatic and non-enzymatic products for cell dissociation, is projected to contribute to the market’s expansion.
In the year 2020, Thermo Fisher Scientific was the market leader. The corporation has a substantial presence in the United States, Europe, Asia, the Middle East, and Africa, as well as the Americas. Furthermore, the company’s significant asset in the cell dissociation industry is its excellent brand awareness and broad product portfolio. In 2020, Merck KgaA ranked second in the cell dissociation market.